NEPHROS, INC. (NEPH) Gross Margin
- Gross margin · 12 months: Value 61.26%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 61.26% | Gross profit / revenue. Period ending 2026-06-30. $12.70M ÷ $20.72M × 100 ≈ 61.26% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 12.70M USD | Gross Profit |
| Revenue | 20.72M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 8.03M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $12.70M | $20.72M | $8.03M | 61.26% |
| 2026-03-31 | $11.46M | $19.12M | $7.66M | 59.95% |
| 2025-12-31 | $11.63M | $18.79M | $7.16M | 61.87% |
| 2025-09-30 | $11.34M | $17.93M | $6.59M | 63.24% |
| 2025-06-30 | $10.57M | $16.68M | $6.11M | 63.37% |
| 2025-03-31 | $9.69M | $15.52M | $5.83M | 62.45% |
| 2024-12-31 | $8.72M | $14.16M | $5.44M | 61.59% |
| 2024-09-30 | $8.27M | $13.55M | $5.28M | 61.04% |
| 2024-06-30 | $8.31M | $13.77M | $5.46M | 60.38% |
| 2024-03-31 | $8.48M | $14.06M | $5.58M | 60.31% |
| 2023-12-31 | $8.40M | $14.24M | $5.83M | 59.03% |
| 2023-09-30 | $7.89M | $13.54M | $5.65M | 58.29% |
| 2023-06-30 | $6.47M | $12.21M | $5.74M | 53.02% |
| 2023-03-31 | $5.79M | $11.51M | $5.72M | 50.28% |
| 2022-12-31 | $4.73M | $9.97M | $5.24M | 47.43% |
| 2022-09-30 | $4.80M | $10.32M | $5.51M | 46.55% |
| 2022-06-30 | $5.27M | $10.47M | $5.21M | 50.29% |
| 2022-03-31 | $5.18M | $9.86M | $4.67M | 52.57% |
| 2021-12-31 | $5.74M | $10.40M | $4.66M | 55.20% |
| 2021-09-30 | $5.58M | $9.97M | $4.40M | 55.91% |
| 2021-06-30 | $5.39M | $9.46M | $4.07M | 56.98% |
| 2021-03-31 | $5.01M | $8.77M | $3.76M | 57.13% |
| 2020-12-31 | $4.91M | $8.56M | $3.65M | 57.39% |
| 2020-09-30 | $5.51M | $9.39M | $3.88M | 58.70% |
| 2020-06-30 | $6.11M | $10.36M | $4.26M | 58.92% |
| 2020-03-31 | $6.58M | $11.09M | $4.52M | 59.28% |
| 2019-12-31 | $6.08M | $10.33M | $4.25M | 58.87% |
| 2019-09-30 | $5.14M | $8.79M | $3.65M | 58.49% |
| 2019-06-30 | $4.27M | $7.41M | $3.14M | 57.61% |
| 2019-03-31 | $3.73M | $6.47M | $2.74M | 57.70% |
| 2018-12-31 | $3.20M | $5.69M | $2.48M | 56.32% |
| 2018-09-30 | $3.04M | $5.38M | (m) | 56.50% |
| 2018-06-30 | $2.62M | $4.57M | (m) | 57.30% |
| 2018-03-31 | $2.30M | $4.06M | (m) | 56.75% |
| 2017-12-31 | $2.29M | $3.81M | (m) | 60.17% |
| 2017-09-30 | $1.89M | $3.25M | (m) | 58.08% |
| 2017-06-30 | $1.67M | $2.81M | (m) | 59.49% |
| 2017-03-31 | $1.45M | $2.46M | (m) | 59.01% |
| 2016-12-31 | $1.29M | $2.32M | (m) | 55.78% |
| 2016-09-30 | $1.16M | $2.09M | (m) | 55.66% |
| 2016-06-30 | $1.01M | $1.93M | (m) | 52.36% |
| 2016-03-31 | $1.07M | $1.99M | (m) | 53.92% |
| 2015-12-31 | $1.06M | $1.94M | (m) | 54.53% |
| 2015-09-30 | $1.02M | $1.77M | (m) | 57.63% |
| 2015-06-30 | $1.17M | $1.95M | (m) | 60.31% |
| 2015-03-31 | $1.11M | $1.82M | (m) | 61.24% |
| 2014-12-31 | $1.20M | $1.75M | (m) | 68.59% |
| 2014-09-30 | $921.00K | $1.63M | (m) | 56.43% |
| 2014-06-30 | $834.00K | $1.56M | (m) | 53.50% |
| 2014-03-31 | $884.00K | $1.69M | (m) | 52.25% |
| 2013-12-31 | $842.00K | $1.74M | (m) | 48.39% |
| 2013-09-30 | $983.00K | $1.88M | (m) | 52.23% |
| 2013-06-30 | $1.17M | $2.07M | (m) | 56.43% |
| 2013-03-31 | $1.08M | $1.79M | (m) | 60.39% |
| 2012-12-31 | $1.07M | $1.81M | (m) | 59.21% |
| 2012-09-30 | $1.15M | $1.93M | (m) | 59.54% |
| 2012-06-30 | $1.04M | $1.73M | (m) | 60.31% |
| 2012-03-31 | $980.00K | $2.07M | (m) | 47.43% |
| 2011-12-31 | $868.00K | $2.21M | (m) | 39.21% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $1.12M | $2.94M | (m) | 38.19% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |